Factory 99% Velpatasvir Powder CAS 1377049-84-7 Chemical Intermediate Anti-Cancer Velpatasvir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A539
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Velpatasvir
• CAS: 1377049-84-7
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Anti-Cancer
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Velpatasvir
Appearance	White Powder
CAS NO.	1377049-84-7
MF	C37H48N8O7P
Storage	Keep in a cool, dry, dark location

 

Velpatasvir is an antiviral medication belonging to the class of drugs known as NS5A inhibitors. It is specifically designed to treat hepatitis C virus (HCV) infections by inhibiting the function of the NS5A protein, which is essential for HCV replication.

 

1. Combination Therapy: Velpatasvir is typically used in combination with other antiviral agents, such as sofosbuvir, to form a complete treatment regimen for HCV.
2. Genotype Coverage: This medication is effective against multiple HCV genotypes, making it a versatile option for patients with different strains of the virus.
3. Cure Rates: Clinical trials have demonstrated high cure rates with velpatasvir-based regimens, offering hope to patients seeking to eliminate their HCV infection.

1. Inhibiting HCV Replication: By inhibiting the NS5A protein, Velpatasvir disrupts the HCV replication cycle, preventing the virus from multiplying and spreading within the body.
2. Reducing Viral Load: As a result of its antiviral activity, Velpatasvir helps to significantly reduce the viral load, or the amount of HCV in the bloodstream.
3. Preventing Resistance: The use of velpatasvir in combination therapy helps to prevent the development of drug resistance, ensuring long-term efficacy and patient outcomes.